Activist Post
The US government will assist the pharmaceutical corporations in finding prescription drugs to treat new diseases.
The focus of this collaboration will identify new uses for drugs that have already been approved by the Food and Drug Administration (FDA). There may be need for new human trials, putting the general public at a health risk. Engaging in experimental trials to classify specific compounds to be utilized for unintended purposes is highly dangerous.
Genetic engineering has led researchers to discover over 4,500 diseases that need pharmaceutical drugs to combat.
'We need to speed the pace at which we are turning discoveries into better health outcomes,' said Dr. Francis Collins, of the National Institutes of Health (NIH). 'NIH looks forward to working with our partners in industry and academia to tackle an urgent need that is beyond the scope of any one organization or sector.'The National Institutes of Health (NIH) will begin working with Pfizer Inc, AstraZeneca Plc and Eli Lilly and Co. in agreements to create compounds to be made available for trial use in a planned project.
